Ethicon Submits Biologic License Application to the FDA for the Fibrin Pad
SOMERVILLE, N.J., Nov. 18, 2010 /PRNewswire/ -- Ethicon, Inc., a worldwide leader in surgical care, announced today that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human Fibrinogen and Human Thrombin), to aid in ...
Read more on redOrbit
Orignal From: Ethicon Submits Biologic License Application to the FDA for the Fibrin Pad
Post a Comment